Managing microRNAs with vector-encoded decoy-type inhibitors

Molecular Therapy

Volumn 21, Issue 8, 2013, Pages 1478-1485

  Bak, Rasmus O ^a   Hollensen, Anne Kruse ^a   Mikkelsen, Jacob Giehm ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING NUCLEIC ACID METABOLISM; CIRCULAR RIBONUCLEIC ACID; DECOY TYPE MICRORNA INHIBITOR; MICRORNA; RNA; RNA INDUCED SILENCING COMPLEX; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; BINDING AFFINITY; DRUG RESEARCH; GENE DELIVERY SYSTEM; GENE MUTATION; GENE TARGETING; GENETIC ENGINEERING; GENETIC REGULATION; GENETIC TRANSDUCTION; HOST PATHOGEN INTERACTION; HUMAN; KNOCKOUT MOUSE; MOLECULAR RECOGNITION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; TISSUE SPECIFICITY; TRANS SPLICING;

ANIMALS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MICRORNAS; ORGAN SPECIFICITY; RNA; RNA INTERFERENCE; RNA, ANTISENSE; TRANS-SPLICING;

EID: 84881315200     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.113     Document Type: Review

References (50)

1. Lagos-Quintana, M, Rauhut, R, Lendeckel, W and Tuschl, T (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
2. Ellwanger, DC, Büttner, FA, Mewes, HW and Stümpflen, V (2011). The sufficient minimal set of miRNA seed types. Bioinformatics 27: 1346-1350.
3. Doench, JG, Petersen, CP and Sharp, PA (2003). siRNAs can function as miRNAs. Genes Dev 17: 438-442.
4. Friedman, RC, Farh, KK, Burge, CB and Bartel, DP (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
5. Liu, YP, Haasnoot, J, ter Brake, O, Berkhout, B and Konstantinova, P (2008). Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 36: 2811-2824.
6. Zeng, Y, Wagner, EJ and Cullen, BR (2002). Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 9: 1327-1333.
7. Esau, CC (2008). Inhibition of microRNA with antisense oligonucleotides. Methods 44: 55-60.
8. van Rooij, E and Olson, EN (2012). MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat Rev Drug Discov 11: 860-872.
9. Janssen, HL, Reesink, HW, Lawitz, EJ, Zeuzem, S, Rodriguez-Torres, M, Patel, K et al. (2013). Treatment of HCV infection by targeting microRNA. N Engl J Med 368: 1685-1694.
10. Krützfeldt, J, Rajewsky, N, Braich, R, Rajeev, KG, Tuschl, T, Manoharan, M et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
11. Kay, MA, He, CY and Chen, ZY (2010). A robust system for production of minicircle DNA vectors. Nat Biotechnol 28: 1287-1289.
12. Xie, J, Ameres, SL, Friedline, R, Hung, JH, Zhang, Y, Xie, Q et al. (2012). Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods 9: 403-409.
13. Gentner, B, Schira, G, Giustacchini, A, Amendola, M, Brown, BD, Ponzoni, M et al. (2009). Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6: 63-66.
14. Ebert, MS, Neilson, JR and Sharp, PA (2007). MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
15. Mullokandov, G, Baccarini, A, Ruzo, A, Jayaprakash, AD, Tung, N, Israelow, B et al. (2012). High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods 9: 840-846.
16. Loya, CM, Lu, CS, Van Vactor, D and Fulga, TA (2009). Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms. Nat Methods 6: 897-903.
17. Ma, F, Xu, S, Liu, X, Zhang, Q, Xu, X, Liu, M et al. (2011). The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-? Nat Immunol 12: 861-869.
18. Sakurai, F, Furukawa, N, Higuchi, M, Okamoto, S, Ono, K, Yoshida, T et al. (2012). Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a. Virus Res 165: 214-218.
19. Park, CY, Choi, YS and McManus, MT (2010). Analysis of microRNA knockouts in mice. Hum Mol Genet 19(R2): R169-R175.
20. Prosser, HM, Koike-Yusa, H, Cooper, JD, Law, FC and Bradley, A (2011). A resource of vectors and ES cells for targeted deletion of microRNAs in mice. Nat Biotechnol 29: 840-845.
21. Park, CY, Jeker, LT, Carver-Moore, K, Oh, A, Liu, HJ, Cameron, R et al. (2012). A resource for the conditional ablation of microRNAs in the mouse. Cell Rep 1: 385-391.
22. Abbott, AL, Alvarez-Saavedra, E, Miska, EA, Lau, NC, Bartel, DP, Horvitz, HR et al. (2005). The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell 9: 403-414.
23. Zhu, Q, Sun, W, Okano, K, Chen, Y, Zhang, N, Maeda, T et al. (2011). Sponge transgenic mouse model reveals important roles for the microRNA-183 (miR-183)/96/182 cluster in postmitotic photoreceptors of the retina. J Biol Chem 286: 31749-31760.
24. Franco-Zorrilla, JM, Valli, A, Todesco, M, Mateos, I, Puga, MI, Rubio-Somoza, I et al. (2007). Target mimicry provides a new mechanism for regulation of microRNA activity. Nat Genet 39: 1033-1037.
25. Tan, H, Poidevin, M, Li, H, Chen, D and Jin, P (2012). MicroRNA-277 modulates the neurodegeneration caused by Fragile X premutation rCGG repeats. PLoS Genet 8: E1002681.
26. Scherr, M, Venturini, L, Battmer, K, Schaller-Schoenitz, M, Schaefer, D, Dallmann, I et al. (2007). Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res 35: E149.
27. Carè, A, Catalucci, D, Felicetti, F, Bonci, D, Addario, A, Gallo, P et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
28. Otaegi, G, Pollock, A and Sun, T (2011). An Optimized Sponge for microRNA miR-9 Affects Spinal Motor Neuron Development in vivo. Front Neurosci 5: 146.
29. An, W and Telesnitsky, A (2001). Frequency of direct repeat deletion in a human immunodeficiency virus type 1 vector during reverse transcription in human cells. Virology 286: 475-482.
30. Bak, RO, Hollensen, AK, Primo, MN, Sørensen, CD and Mikkelsen, JG (2013). Potent microRNA suppression by RNA Pol II-transcribed 'Tough Decoy' inhibitors. RNA 19: 280-293.
31. Chi, SW, Zang, JB, Mele, A and Darnell, RB (2009). Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460: 479-486.
32. Doench, JG and Sharp, PA (2004). Specificity of microRNA target selection in translational repression. Genes Dev 18: 504-511.
33. Haraguchi, T, Ozaki, Y and Iba, H (2009). Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 37: E43.
34. Hollensen, AK, Bak, RO, Haslund, D and Mikkelsen, JG (2013). Suppression of microRNAs by dual-targeting and clustered Tough Decoy inhibitors. RNA Biol 10: 406-414.
35. Haraguchi, T, Nakano, H, Tagawa, T, Ohki, T, Ueno, Y, Yoshida, T et al. (2012). A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures. Nucleic Acids Res 40: E58.
36. Ameres, SL, Horwich, MD, Hung, JH, Xu, J, Ghildiyal, M, Weng, Z et al. (2010). Target RNA-directed trimming and tailing of small silencing RNAs. Science 328: 1534-1539.
37. Baccarini, A, Chauhan, H, Gardner, TJ, Jayaprakash, AD, Sachidanandam, R and Brown, BD (2011). Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Curr Biol 21: 369-376.
38. Wang, X, Han, L, Zhang, A, Wang, G, Jia, Z, Yang, Y et al. (2011). Adenovirusmediated shRNAs for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells. Oncol Rep 25: 97-105.
39. Druz, A, Son, YJ, Betenbaugh, M and Shiloach, J (2013). Stable inhibition of mmumiR-466h-5p improves apoptosis resistance and protein production in CHO cells. Metab Eng 16: 87-94.
40. Ameres, SL, Martinez, J and Schroeder, R (2007). Molecular basis for target RNA recognition and cleavage by human RISC. Cell 130: 101-112.
41. Choi, WY, Giraldez, AJ and Schier, AF (2007). Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318: 271-274.
42. Wang, Z (2011). The principles of MiRNA-masking antisense oligonucleotides technology. Methods Mol Biol 676: 43-49.
43. Seitz, H (2009). Redefining microRNA targets. Curr Biol 19: 870-873.
44. Almeida, MI, Reis, RM and Calin, GA (2012). Decoy activity through microRNAs: The therapeutic implications. Expert Opin Biol Ther 12: 1153-1159.
45. Wee, LM, Flores-Jasso, CF, Salomon, WE and Zamore, PD (2012). Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell 151: 1055-1067.
46. Garcia, DM, Baek, D, Shin, C, Bell, GW, Grimson, A and Bartel, DP (2011). Weak seedpairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18: 1139-1146.
47. Hansen, TB, Jensen, TI, Clausen, BH, Bramsen, JB, Finsen, B, Damgaard, CK et al. (2013). Natural RNA circles function as efficient microRNA sponges. Nature 495: 384-388.
48. Memczak, S, Jens, M, Elefsinioti, A, Torti, F, Krueger, J, Rybak, A et al. (2013). Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495: 333-338.
49. Jeck, WR, Sorrentino, JA, Wang, K, Slevin, MK, Burd, CE, Liu, J et al. (2013). Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19: 141-157.
50. Jopling, CL, Yi, M, Lancaster, AM, Lemon, SM and Sarnow, P (2005). Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.